Understanding genetic risks of prostate cancer can help individuals take proactive steps to protect their health.

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...

Prostate cancer is a growing problem in men, and advanced cases are rising for the first time in 20 years, which is why ...

Scientists uncover functionality of a genetic variant in the prostate specific antigen (PSA) gene to improve the current diagnostic test to help distinguish aggressive from non-aggressive prostate ...

Routt County resident James Onufrak knew his dad was diagnosed with prostate cancer at age 61, so he worked with his own ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

“The persons that we have seen for prostate cancer: If you look at the chart ... across the country more men are taking the prostate-specific antigen (PSA) blood test and in some cases biopsies are ...

People may prefer to get screened for colorectal cancer with a blood test rather than a colonoscopy. But more than twice as many colorectal cancer deaths would occur with blood-based screening as ...

You are correct that a saliva test that flags a high risk of prostate cancer is under development. Unlike a blood test, a ...

“If you can detect prostate cancer early, then typically theres a 97-98 percent five year survival rate for the disease if ...